Breakthroughs

Prostate cancer MRI scans: is the NHS ready?

05/19/2019Breakthroughs, Cancer Detection & Screening Guidelines

All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy. And it’s a decision that prostate cancer expert Professor Mark Emberton is extremely happy about. Read the original article at: https://scienceblog.cancerresearchuk.org/2019/05/09/prostate-cancer-mri-scans-is-the-nhs-ready/

News digest – NHS staff shortages, HPV vaccine in Rwanda, prostate cancer guidelines and sunscreen chemicals

05/19/2019Awareness, Breakthroughs, Cancer Prevention & Treatments, Global Cancer News, News

Read about this week News Digest's cancer research breakthrough headlines including National screening programs, a new drug for aggressive childhood brain cancer, HPV vaccination in Rwanda, and more. Original article at: https://scienceblog.cancerresearchuk.org/2019/05/11/news-digest-nhs-staff-shortages-hpv-vaccine-in-rwanda-prostate-cancer-guidelines-and-sunscreen-chemicals/

Cancer Research UK to test targeted drug in pancreatic cancer

05/19/2019Breakthroughs

A dual kinase inhibitor* is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine as part of Cancer Research UK’s Combinations Alliance. The novel combination of drugs targets the process of nerve invasion, observed in over 80% of pancreatic ductal adenocarcinoma…

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

05/19/2019Breakthroughs

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. They say the decision will benefit approximately 2,100 patients a year. Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-05-17-cancer-drug-approved-for-nhs-use-in-england-gives-some-multiple-myeloma-patients-another-option

AFCR-Supported Scientist Discovers Critical Molecular Interaction, Opens New Avenue for Cancer Drug Development

08/08/2018Breakthroughs, Cancer Scientists

(Hong Kong, April 13, 2015) Prof. Mingjie Zhang of Hong Kong University of Science and Technology, a scientist supported by the Asian Fund for Cancer Research (AFCR), recently discovered a critical molecular interaction governing epithelial cell polarity – a crucial factor in…

Prostate cancer MRI scans: is the NHS ready?

News digest – NHS staff shortages, HPV vaccine in Rwanda, prostate cancer guidelines and sunscreen chemicals

Cancer Research UK to test targeted drug in pancreatic cancer

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

AFCR-Supported Scientist Discovers Critical Molecular Interaction, Opens New Avenue for Cancer Drug Development

Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

Breakthroughs in understanding the genetic basis of aggressive prostate cancer

UNC cancer research finds success with compound treatments

Accelerate Brain Cancer Cure (ABC2) Drives Breakthroughs in Research

New Breakthroughs in Omega-3 Research